Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Concert Pharmaceuticals reports Q1 EPS (70c), consensus (78c) » 07:28
04/30/20
04/30
07:28
04/30/20
07:28
CNCE

Concert Pharmaceuticals

$11.28 /

+0.76 (+7.22%)

Reports Q1 revenue…

Reports Q1 revenue $7,000, consensus $10,000. "We are continuing to move forward the development of our two clinical drug candidates. Following discussions with the FDA at an End-of-Phase 2 meeting in March, CTP-543 is on the cusp of initiating its Phase 3 clinical program for the treatment of moderate-to-severe alopecia areata later this year. In addition, despite challenges in enrollment due to COVID-19, we have been successful in keeping our Phase 2 trial of CTP-692 up and running and currently expect to complete enrollment by year-end 2020," stated Roger Tung, Ph.D., President and CEO of Concert Pharmaceuticals. "We are closely monitoring our clinical programs and are actively working with all of the stakeholders involved so that we can attempt to minimize the impact of COVID-19."

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$11.28 /

+0.76 (+7.22%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Over a month ago
Conference/Events
Concert Pharmaceuticals management to meet virtually with JMP Securities » 04:55
04/16/20
04/16
04:55
04/16/20
04:55
CNCE

Concert Pharmaceuticals

$9.78 /

-0.62 (-5.96%)

Virtual Meeting to be…

Virtual Meeting to be held on April 16 hosted by JMP Securities.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$9.78 /

-0.62 (-5.96%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Conference/Events
Concert Pharmaceuticals management to meet virtually with JMP Securities » 11:29
04/15/20
04/15
11:29
04/15/20
11:29
CNCE

Concert Pharmaceuticals

$9.64 /

-0.76 (-7.31%)

Virtual Meeting to be…

Virtual Meeting to be held on April 16 hosted by JMP Securities.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$9.64 /

-0.76 (-7.31%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Conference/Events
Concert Pharmaceuticals participates in a conference call with SunTrust » 13:25
04/14/20
04/14
13:25
04/14/20
13:25
CNCE

Concert Pharmaceuticals

$10.23 /

+0.36 (+3.65%)

Healthcare Analyst Lee…

Healthcare Analyst Lee holds a conference call with President & CEO Tung and CFO Becker on April 14 at 2 pm hosted by SunTrust.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$10.23 /

+0.36 (+3.65%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Conference/Events
Concert Pharmaceuticals participates in a conference call with SunTrust » 04:55
04/14/20
04/14
04:55
04/14/20
04:55
CNCE

Concert Pharmaceuticals

$9.87 /

+0.37 (+3.89%)

Healthcare Analyst Lee…

Healthcare Analyst Lee holds a conference call with President & CEO Tung and CFO Becker on April 14 at 2 pm hosted by SunTrust.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$9.87 /

+0.37 (+3.89%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Conference/Events
Concert Pharmaceuticals participates in a conference call with Mizuho » 04:55
04/09/20
04/09
04:55
04/09/20
04:55
CNCE

Concert Pharmaceuticals

$9.57 /

+1.48 (+18.29%)

Conference call with…

Conference call with management will be held on April 9 hosted by Mizuho.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$9.57 /

+1.48 (+18.29%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Conference/Events
Concert Pharmaceuticals participates in a conference call with SunTrust » 15:26
04/08/20
04/08
15:26
04/08/20
15:26
CNCE

Concert Pharmaceuticals

$9.51 /

+1.42 (+17.55%)

Healthcare Analyst Lee…

Healthcare Analyst Lee holds a conference call with President & CEO Tung and CFO Becker on April 14 at 2 pm hosted by SunTrust.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$9.51 /

+1.42 (+17.55%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Conference/Events
Concert Pharmaceuticals participates in a conference call with Mizuho » 12:27
04/02/20
04/02
12:27
04/02/20
12:27
CNCE

Concert Pharmaceuticals

$7.97 /

+0.17 (+2.18%)

Conference call with…

Conference call with management will be held on April 9 hosted by Mizuho.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$7.97 /

+0.17 (+2.18%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Hot Stocks
Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials » 07:07
04/01/20
04/01
07:07
04/01/20
07:07
CNCE

Concert Pharmaceuticals

$8.80 /

-0.29 (-3.19%)

Concert Pharmaceuticals…

Concert Pharmaceuticals announced the details of its pivotal Phase 3 trials of CTP-543 in patients with moderate-to-severe alopecia areata, an autoimmune disorder that results in patchy or complete hair loss. Concert discussed key aspects of its planned Phase 3 trials in adult patients with the FDA at a recently conducted End-of-Phase 2 meeting. The Phase 3 program is intended to support filing of a New Drug Application for CTP-543. The planned Phase 3 program for CTP-543 will include two randomized, double-blind, placebo-controlled clinical trials in adults at sites in the U.S., Canada and Europe. The Phase 3 program will evaluate the Severity of Alopecia Tool, or SALT, score after 24 weeks of dosing in patients with moderate-to-severe alopecia areata.

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$8.80 /

-0.29 (-3.19%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
Initiation
Fly Intel: Top five analyst initiations » 10:11
03/30/20
03/30
10:11
03/30/20
10:11
BSGM

BioSig Technologies

$5.11 /

-0.04 (-0.78%)

, LLNW

Limelight Networks

$5.40 /

+0.16 (+3.05%)

, ATSG

Air Transport Services

$17.09 /

-0.09 (-0.52%)

, CNCE

Concert Pharmaceuticals

$9.45 /

+0.08 (+0.85%)

, GFL

GFL Environmental

$14.62 /

-0.33 (-2.21%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BioSig Technologies (BSGM) initiated with a Buy at Roth Capital. 2. Limelight Networks (LLNW) initiated with an Outperform at Northland. 3. Air Transport Services (ATSG) initiated with a Hold at Loop Capital. 4. Concert Pharmaceuticals (CNCE) initiated with a Buy at Jefferies. 5. GFL Environmental (GFL) initiated with an Overweight at JPMorgan, an Outperform at Raymond James and Scotiabank, a Buy at Stifel, an Equal Weight at Barclays, and a Neutral at Goldman Sachs, BofA, and CIBC. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
BSGM BioSig Technologies
$5.11 /

-0.04 (-0.78%)

03/30/20 Roth Capital
BioSig Technologies initiated with a Buy at Roth Capital
LLNW Limelight Networks
$5.40 /

+0.16 (+3.05%)

03/30/20 Northland
Limelight Networks initiated with an Outperform at Northland
03/06/20
Fly Intel: Top five analyst initiations
03/06/20 William Blair
Limelight Networks initiated with an Outperform at William Blair
01/08/20 Craig-Hallum
Craig-Hallum names Ebix, Limelight, Upland Software top picks for 2020
ATSG Air Transport Services
$17.09 /

-0.09 (-0.52%)

03/30/20 Loop Capital
Air Transport Services initiated with a Hold at Loop Capital
03/20/20
Fly Intel: Top five analyst initiations
03/20/20 Benchmark
Air Transport Services initiated with a Buy at Benchmark
12/27/19 Stephens
Fiserv, SurveyMonkey among stocks dropped from Stephens Best Ideas list
CNCE Concert Pharmaceuticals
$9.45 /

+0.08 (+0.85%)

03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
01/22/20 JMP Securities
Concert Pharmaceuticals price target raised to $25 from $13 at JMP Securities
GFL GFL Environmental
$14.62 /

-0.33 (-2.21%)

03/30/20 JPMorgan
GFL Environmental initiated with an Overweight at JPMorgan
03/30/20 Raymond James
GFL Environmental initiated with an Outperform at Raymond James
03/30/20 Barclays
GFL Environmental initiated with an Equal Weight at Barclays
03/30/20 BofA
GFL Environmental initiated with a Neutral at BofA

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.